Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.64B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$928M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$804M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$765M |
Top Sells
| 1 |
CRH
CRH
|
+$771M |
| 2 |
Bank of America
BAC
|
+$711M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$536M |
| 4 |
NVIDIA
NVDA
|
+$481M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$417M |
Sector Composition
| 1 | Technology | 29.49% |
| 2 | Financials | 11.51% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Healthcare | 10.02% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUM
1026
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $10.5M | ﹤0.01% |
274,265
+172,825
| +170% | +$6.65M |
|
1027
Goodyear
GT
$2.45B
| $10.5M | ﹤0.01% |
734,824
-411,932
| -36% | -$5.9M |
|
|
AMED
1028
DELISTED
Amedisys
AMED
| $10.5M | ﹤0.01% |
110,631
-16,934
| -13% | -$1.61M |
|
1029
Casey's General Stores
CASY
$20.6B
| $10.5M | ﹤0.01% |
38,162
+16,282
| +74% | +$4.47M |
|
1030
Teva Pharmaceuticals
TEVA
$22.8B
| $10.5M | ﹤0.01% |
1,001,181
-117,021
| -10% | -$1.22M |
|
1031
Cheniere Energy
CQP
$25.8B
| $10.4M | ﹤0.01% |
209,848
+58,821
| +39% | +$2.93M |
|
1032
Synaptics
SYNA
$2.76B
| $10.4M | ﹤0.01% |
90,965
+54,454
| +149% | +$6.21M |
|
1033
Insmed
INSM
$30.8B
| $10.4M | ﹤0.01% |
334,529
+162,728
| +95% | +$5.04M |
|
1034
PotlatchDeltic
PCH
$3.3B
| $10.4M | ﹤0.01% |
210,826
+144,213
| +216% | +$7.08M |
|
1035
Eagle Materials
EXP
$7.7B
| $10.3M | ﹤0.01% |
51,009
+8,822
| +21% | +$1.79M |
|
1036
Skechers
SKX
$9.49B
| $10.3M | ﹤0.01% |
165,832
-16,757
| -9% | -$1.04M |
|
1037
Five Below
FIVE
$8.04B
| $10.3M | ﹤0.01% |
48,457
-120,062
| -71% | -$25.6M |
|
1038
Amicus Therapeutics
FOLD
$2.47B
| $10.3M | ﹤0.01% |
727,775
+315,339
| +76% | +$4.48M |
|
1039
Keros Therapeutics
KROS
$640M
| $10.3M | ﹤0.01% |
259,760
+210,249
| +425% | +$8.36M |
|
1040
Sanofi
SNY
$116B
| $10.3M | ﹤0.01% |
207,069
+20,876
| +11% | +$1.04M |
|
1041
iShares Silver Trust
SLV
$20.4B
| $10.2M | ﹤0.01% |
470,118
+42,482
| +10% | +$925K |
|
1042
Lyft
LYFT
$7.6B
| $10.2M | ﹤0.01% |
682,067
+212,123
| +45% | +$3.18M |
|
1043
Flowserve
FLS
$7.41B
| $10.2M | ﹤0.01% |
247,902
+106,079
| +75% | +$4.37M |
|
1044
Haemonetics
HAE
$2.58B
| $10.2M | ﹤0.01% |
118,899
+81,303
| +216% | +$6.95M |
|
1045
Revolution Medicines
RVMD
$8.64B
| $10.1M | ﹤0.01% |
353,785
+125,124
| +55% | +$3.59M |
|
1046
FIVE9
FIVN
$2.02B
| $10.1M | ﹤0.01% |
128,834
-21,384
| -14% | -$1.68M |
|
1047
First Industrial Realty Trust
FR
$6.97B
| $10.1M | ﹤0.01% |
192,015
+74,836
| +64% | +$3.94M |
|
1048
Tri Pointe Homes
TPH
$3.18B
| $10.1M | ﹤0.01% |
285,175
+125,944
| +79% | +$4.46M |
|
1049
Insight Enterprises
NSIT
$4.07B
| $10M | ﹤0.01% |
56,715
+35,343
| +165% | +$6.26M |
|
1050
Viking Therapeutics
VKTX
$2.89B
| $10M | ﹤0.01% |
539,713
+17,791
| +3% | +$331K |
|